Doctor profile · Federal record

Dr. Chelsea Hoover, CRNP

Nurse Practitioner · Huntsville, AL

  • NPI 1497366744
  • Accepts Medicare
  • MIPS 92.4 / 100 · 2023
  • 8 yrs in practice
  • Female
  • Solo practice
  • No sanctions

Practice & contact

NPPES Updated May 11, 2026
Primary practice
201A Longwood Dr Se
Huntsville, AL 358012742
(877) 231-3376
fax (850) 522-8354
Mailing address
2505 Harrison Ave
Panama City, FL 324054464

Credentials & registration

NPPES · NUCC
NPI registered
August 2020 — 6 yrs on file
Profile last updated
January 16, 2026
Year of graduation
2018 — 8 yrs since
Specialty taxonomy
363L00000X — NUCC code
State license (1)
Alabama #1-138904

Federal sanctions & exclusions

OIG LEIE Updated May 11, 2026

No sanctions, exclusions or revocations on file

Checked against OIG LEIE on NPI 1497366744. Last verified May 11, 2026.

Medicare procedures · 2023

Top services delivered

CMS Provider Utilization
Total services
1,822
Distinct HCPCS
10
Medicare allowed
$80,578
HCPCS Description Services Patients Avg allowed
17003 Destruction of precancer skin growth, 2-14 growths 741 130 $5
99213 Established patient office or other outpatient visit, 20-29 minutes 307 248 $70
17000 Destruction of precancer skin growth, 1 growth 211 176 $40
11102 Biopsy of related skin growth, first growth 140 129 $72
17110 Destruction of skin growth, 1-14 growths 102 91 $86
11103 Biopsy of related skin growth, each additional growth 84 51 $39
99203 New patient office or other outpatient visit, 30-44 minutes 62 62 $89
99212 Established patient office or other outpatient visit, 10-19 minutes 56 55 $44
99214 Established patient office or other outpatient visit, 30-39 minutes 56 51 $101
17004 Destruction of precancer skin growth, 15 or more growths 20 18 $132

In context: peer comparison

Among 26 peers in this city , average services per provider: 66. This provider delivers 28× the peer median.

Open Payments

Industry payments received

CMS Open Payments
All-time total
$2,914
Transactions
130
Manufacturers
15
Payer (manufacturer) Industry Txns Amount
GENZYME CORPORATION 18 $437.14
Janssen Biotech, Inc. 12 $429.17
ABBVIE INC. 20 $388.61
SUN PHARMACEUTICAL INDUSTRIES INC. 10 $332.56
Novartis Pharmaceuticals Corporation 15 $331.30
Regeneron Healthcare Solutions, Inc. 10 $282.23
E.R. Squibb & Sons, L.L.C. 21 $182.91
LEO Pharma Inc. 5 $109.52
Ortho Dermatologics, a division of Bausch Health US, LLC 5 $85.20
Amgen Inc. 4 $79.24
MAYNE PHARMA COMMERCIAL LLC 2 $66.81
Dermavant Sciences, Inc. 3 $51.72
Boehringer Ingelheim Pharmaceuticals, Inc. 2 $37.35
Galderma Laboratories, L.P. 2 $34.59
Boston Scientific Corporation 1 $26.76

By nature of payment

Food and Beverage
$2,720
Education
$193

Medicare Part D · 2023

Top prescriptions

CMS Part D Prescriber
Total claims
440
Patients
241
Total drug cost
$28,897
Drug Type Claims Patients Total cost
Clobetasol Propionate Generic 72 55 $4,149
Ketoconazole Generic 70 39 $1,714
Triamcinolone Acetonide Generic 69 45 $972
Doxycycline Hyclate Generic 54 25 $2,298
Clindamycin Phosphate Generic 37 20 $3,479
Desonide Generic 23 17 $1,989
Metronidazole Generic 20 12 $1,416
Ammonium Lactate Generic 17 13 $451
Mupirocin Generic 16 15 $195
Ciclopirox Generic 14 0 $743

Frequently asked questions

Auto-generated from federal data
What is Dr. Chelsea Hoover's medical specialty?
Dr. Chelsea Hoover practices Nurse Practitioner in Huntsville, AL.
Where does Dr. Chelsea Hoover practice?
Dr. Chelsea Hoover practices at 201A Longwood Dr Se, Huntsville, AL 358012742. Office phone: 8772313376.
What is Dr. Chelsea Hoover's NPI?
Dr. Chelsea Hoover's National Provider Identifier (NPI) is 1497366744, issued by NPPES.
Does Dr. Chelsea Hoover accept Medicare assignment?
Yes. Dr. Chelsea Hoover accepts Medicare assignment, meaning Medicare-allowed amounts are accepted as full payment for covered services.
What procedures does Dr. Chelsea Hoover commonly perform?
Top Medicare-reported procedures in 2023: Destruction of precancer skin growth, 2-14 growths (HCPCS 17003); Established patient office or other outpatient visit (HCPCS 99213); Destruction of precancer skin growth, 1 growth (HCPCS 17000). Source: CMS Medicare Physician & Other Practitioners file.